Blog Posts in June, 2016

Blog Home
  • Benicar Website Omits Sprue-like Enteropathy

    Posted By Golomb & Honik, P.C. || 21-Jun-2016

    While credit is due to Benicar manufacturer, Daiichi Sankyo, for listing the potential side effects of Benicar on the main Benicar landing page—saving the consumer from having to go from one link to another—the company appears to have omitted one of the primary side effects of the drug. While the site lists various side effects with the drug used to regulate blood pressure, such as ...
    Continue Reading
  • Foot and Leg Amputation & Invokana

    Posted By Golomb & Honik, P.C. || 14-Jun-2016

    A new safety alert sent out by the FDA associates the drugs Invokana and Invokamet (canagliflozin) with nearly twice the risk of leg and foot amputations compared with those taking a placebo. These results came from an ongoing clinical trial known as CANVAS (Canagliflozin Cardiovascular Assessment Study). The safety alert followed a four-and-a-half year interim analysis by an independent CANVAS ...
    Continue Reading
  • Voided Blood Tests

    Posted By Golomb & Honik, P.C. || 9-Jun-2016

    Theranos, Inc., through its founder, Elizabeth Holmes, has made the decision to void two entire years’ worth of results from hundreds of its “Edison” blood-testing machines—those from 2014 and 2015. This move encompasses sending tens of thousands of corrected reports to patients and doctors, which raises the question of just how many serious health care decisions could have ...
    Continue Reading
  • Understanding the Dangers of Benicar

    Posted By Golomb & Honik, P.C. || 3-Jun-2016

    There is currently an epidemic of high blood pressure in the United States. Almost one out of every three adults across the nation has the disease, however only about half of those have it under control. Among those 65 and older, high blood pressure will affect more women than men, and is a primary or contributing cause of more than 1,000 deaths each day. While there are many medications used to ...
    Continue Reading
  • PPI Drugs and Chronic Kidney Disease

    Posted By Golomb & Honik, P.C. || 2-Jun-2016

    As the potential dangers of proton pump inhibitor drugs—such as Prilosec, Prevacid and Nexium—continue to come to the light, the most recent study has shown an increased risk of chronic kidney disease among those taking PPI drugs for extended periods of time. PPI drugs were never intended to become a daily pill for Americans – in fact, when the drugs were first approved by the ...
    Continue Reading
  • Xarelto Lawsuits Consolidated into MDL 2592

    Posted By Golomb & Honik, P.C. || 1-Jun-2016

    A hearing held on December 4, 2015 resulted in the Judicial Panel concluding a multi-district litigation was in order to more efficiently take care of the more than 2,800 Xarelto cases that have been filed against Bayer AG and Janssen Pharmaceuticals. MDL consolidation results in faster litigation, as discovery issues are facilitated and conflicting rulings by multiple pre-trial drugs are ...
    Continue Reading
  • 6 results found. Viewing page 1 of 1.